We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid Test Kit Detects Dengue Antibodies in Saliva

By LabMedica International staff writers
Posted on 09 Feb 2015
A paper-based disposable device has been developed that will allow dengue-specific antibodies to be detected easily from saliva within 20 minutes and the device is currently undergoing further development.

Paper-based immunoassays, usually in the form of lateral flow tests, are currently the standard platform for home diagnostics. More...
However, conventional lateral tests are often complicated by severe nonspecific adsorption of detector particles when applied to test samples containing salivary fluid.

Scientists at the Institute of Bioengineering and Nanotechnology (The Nanos; Singapore) developed a stacking flow device consisting of a test strip, a sample pad, a reagent pad, an absorbent pad, and a flow regulator. The sample and reagent pads were made of glass fiber, and the absorbent pad was made of cellulose (Merck Millipore, Billerica, Massachusetts, USA). The nitrocellulose test strip was cut into the required dimensions manually with a roller cutter. The detection of dengue-specific immunoglobulin G (IgG) was conducted using the liquid conjugate approach. The liquid conjugate was composed of protein G-conjugated 40 nm gold nanoparticles.

In the device, different flow paths are created for samples and reagents through a multiple stacked system. This allows the saliva sample to flow separately through a fiber glass matrix, which removes the substances that would interfere with the nanoparticle-based sensing system before it mixes with the sensor nanoparticles. The device’s configuration also helps to regulate the flow in the test strip, generating uniform test lines for more accurate results. The stacking flow immunoassay platform requires only one user activation step: both the sample and reagents are added at the same time in a single step. Both the sample and reagents react and flow concurrently in the test strip. The single-step procedure significantly improved the ease of usage of the test kit. The study was published on January 12, 2015, in the journal Lab on a Chip.

Related Links:

Institute of Bioengineering and Nanotechnology
Merck Millipore  



New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Modular Hemostasis Automation Solution
CN Track
New
PlGF Test
Quidel Triage PlGF Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.